Press Releases
Search
-
23 May 2005
Prospectus about a share buy back program to be submitted at the shareholders' meeting to be held on June 9, 2005
Marcy l'Etoile, France - May 23, 2005.
-
29 Apr 2005
Roche Diagnostics and bioMérieux announce that Roche has granted non exclusive rights for cardiac markers NT-proBNP to bioMérieux
Marcy l’Etoile, France - April 29, 2005. Roche Diagnostics and bioMérieux announced today, that bioMérieux has been granted a nonexclusive license agreement under the patent rights of Roche Diagnostic...
-
20 Apr 2005
First-Quarter 2005 Sales Stable at Constant Exchange Rates
Marcy l'Etoile, France - April 20, 2005. bioMérieux, a global leader in the field of in vitro diagnostics, today announced its first-quarter 2005 sales.
-
15 Apr 2005
bioMérieux invests in the future of emergency diagnostics
Marcy l’Etoile, France - April 15, 2005. A world leader in the field of in vitro diagnostics, with over 40 years experience in infectious diseases, bioMérieux SA recently confirmed its commitment to t...
-
05 Apr 2005
Affymetrix and bioMérieux Extend Their Agreement on GeneChip® Technology to Breast Cancer Diagnostics
Santa Clara, Calif., US and Marcy l’Etoile, France - April 5, 2005. The agreement includes an option for bioMérieux to use Affymetrix GeneChip® technology in other cancer areas. Affymetrix Inc. (Nasda...
-
25 Mar 2005
NucliSens® miniMAG™, bioMérieux’s next generation nucleic acid extraction platform is now available as CE-IVD approved platform
Marcy l'Etoile, France - March 25, 2005. bioMérieux announces the introduction of the NucliSens miniMAG and NucliSens Magnetic Extraction Reagents as CE-IVD marked products. A major actor in the field...